Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ngs_agd
    Junior Member
    • Feb 2011
    • 7

    #1

    duplicate reads in enriched samples

    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.
  • Seq84
    Member
    • Feb 2011
    • 19

    #2
    Originally posted by ngs_agd View Post
    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.
    I'm interesting in this issue too, in our target resequencing experiment we detected a wide range of % in duplicates (from 2 to 80 %). Is it normal that in a target reseq experiment % of duplicates raise?

    Comment

    • Heisman
      Senior Member
      • Dec 2010
      • 534

      #3
      I said in another thread that I communicated by email with an Agilent rep and the main determining factor to duplicates is the number of PCR cycles pre-hybridization. With 7 or 8 cycles I see < 5% duplicates.

      Comment

      • Seq84
        Member
        • Feb 2011
        • 19

        #4
        Thanks for your reply Heisman, next time will decrease number of cycles!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...